SCHEMBL9834972

SCHEMBL9834972

CC1Nc2cc3c(cc2N1)C(C)(C)C(=O)N3

nearest known ligand 0.50

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ATAD2 Q6PL18 1/20 0.50
PDE3B Q13370 8/20 0.44
PDE3A Q14432 8/20 0.44
PDE4A P27815 7/20 0.44
PDE4B Q07343 7/20 0.44
PDE4C Q08493 7/20 0.44
PDE4D Q08499 7/20 0.44
PDK2 Q15119 1/20 0.44
PDK4 Q16654 1/20 0.44
PGR P06401 9/20 0.41
AURKA O14965 1/20 0.37
AURKB Q96GD4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9835182 0.84 ATAD2 (0.49) ATAD2PDE3BPDE3APDE4APDE4B
SCHEMBL10667579 0.84 ATAD2 (0.49) ATAD2PDE3BPDE3APDE4APDE4B
SCHEMBL9836092 0.84 ATAD2 (0.49) ATAD2PDE3BPDE3APDE4APDE4B
Bromide SCHEMBL10555130 0.82 ATAD2 (0.47) ATAD2PDE3BPDE3APDE4APDE4B
SCHEMBL9835030 0.81 ATAD2 (0.46) ATAD2PDE3BPDE3APDE4APDE4B
SCHEMBL9834224 0.81 ATAD2 (0.46) ATAD2PDE3BPDE3APDE4APDE4B
SCHEMBL9834593 0.81 ATAD2 (0.46) ATAD2PDE3BPDE3APDE4APDE4B
SCHEMBL9835356 0.81 ATAD2 (0.46) ATAD2PDE3BPDE3APDE4APDE4B
SCHEMBL9835652 0.81 ATAD2 (0.46) ATAD2PDE3BPDE3APDE4APDE4B
SCHEMBL10664950 0.80 ATAD2 (0.43) ATAD2PDE3BPDE3APDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4730003-A Tricyclic compounds for treating heart and circulatory diseases BOEHRINGER MANNHEIM GMBH (DE) 1988-03-08 US claimed
EP-0214592-B1 PYRROLOBENZIMIDAZOLES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE PRODUCTS Roche Diagnostics GmbH (DE) 1991-08-14 EP disclosed
US-4730003-A Tricyclic compounds for treating heart and circulatory diseases BOEHRINGER MANNHEIM GMBH (DE) 1988-03-08 US disclosed
EP-0214592-A2 Pyrrolobenzimidazoles, process for their preparation and medicaments containing these products Roche Diagnostics GmbH (DE) 1987-03-18 EP disclosed